Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Intravenous Immunoglobulins market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.6% during the forecast period.
This report presents the market size and development trends by detailing the Intravenous Immunoglobulins market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Intravenous Immunoglobulins market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Intravenous Immunoglobulins industry and will help you to build a panoramic view of the industrial development.
Intravenous Immunoglobulins Market, By Type:
Neurology Intravenous Immunoglobulins
Hematology Intravenous Immunoglobulins
Immunology Intravenous Immunoglobulins
Intravenous Immunoglobulins Market, By Application:
Primary Immunodeficiency
Idiopathic Thrombocytopenic Purpura
Chronic Inflammatory Demyelinating Polyneuropathy
Kawasaki Disease
Guillain-Barre Syndrome
Some of the leading players are as follows:
Hualan Biological Engineering
Biotest
LFB Group
Octapharma
Bayer
Grifols
Shire
Bharat Serum and Vaccines
ADMA Biologics
China Biologic Products
Kedrion Biopharma
Sanquin
CSL Behring
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Intravenous Immunoglobulins Market: Technology Type Analysis
-
4.1 Intravenous Immunoglobulins Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Intravenous Immunoglobulins Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Neurology Intravenous Immunoglobulins
4.3.2 Hematology Intravenous Immunoglobulins
4.3.3 Immunology Intravenous Immunoglobulins
5 Intravenous Immunoglobulins Market: Product Analysis
-
5.1 Intravenous Immunoglobulins Product Market Share Analysis, 2018 & 2026
-
5.2 Intravenous Immunoglobulins Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Intravenous Immunoglobulins Market: Application Analysis
-
6.1 Intravenous Immunoglobulins Application Market Share Analysis, 2018 & 2026
-
6.2 Intravenous Immunoglobulins Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Primary Immunodeficiency
6.3.2 Idiopathic Thrombocytopenic Purpura
6.3.3 Chronic Inflammatory Demyelinating Polyneuropathy
6.3.4 Kawasaki Disease
6.3.5 Guillain-Barre Syndrome
7 Intravenous Immunoglobulins Market: Regional Analysis
-
7.1 Intravenous Immunoglobulins Regional Market Share Analysis, 2018 & 2026
-
7.2 Intravenous Immunoglobulins Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Hualan Biological Engineering
9.1.1 Hualan Biological Engineering Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Biotest
9.2.1 Biotest Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 LFB Group
9.3.1 LFB Group Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Octapharma
9.4.1 Octapharma Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Bayer
9.5.1 Bayer Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Grifols
9.6.1 Grifols Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Shire
9.7.1 Shire Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Bharat Serum and Vaccines
9.8.1 Bharat Serum and Vaccines Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 ADMA Biologics
9.9.1 ADMA Biologics Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 China Biologic Products
9.10.1 China Biologic Products Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Kedrion Biopharma
9.11.1 Kedrion Biopharma Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Sanquin
9.12.1 Sanquin Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 CSL Behring
9.13.1 CSL Behring Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
The List of Tables and Figures (Totals 102 Figures and 150 Tables)
Figure Neurology Intravenous Immunoglobulins Intravenous Immunoglobulins market, 2015 - 2026 (USD Million)
Figure Hematology Intravenous Immunoglobulins Intravenous Immunoglobulins market, 2015 - 2026 (USD Million)
Figure Immunology Intravenous Immunoglobulins Intravenous Immunoglobulins market, 2015 - 2026 (USD Million)
Figure Primary Immunodeficiency market, 2015 - 2026 (USD Million)
Figure Idiopathic Thrombocytopenic Purpura market, 2015 - 2026 (USD Million)
Figure Chronic Inflammatory Demyelinating Polyneuropathy market, 2015 - 2026 (USD Million)
Figure Kawasaki Disease market, 2015 - 2026 (USD Million)
Figure Guillain-Barre Syndrome market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Intravenous Immunoglobulins market, by country, 2015 - 2026 (USD Million)
-
Table North America Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table North America Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table North America Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table Canada Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table Canada Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Europe Intravenous Immunoglobulins market, by country, 2015 - 2026 (USD Million)
-
Table Europe Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table Europe Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table Europe Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table Germany Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table Germany Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table France Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table France Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table Italy Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table Italy Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table Spain Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table Spain Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Intravenous Immunoglobulins market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table China Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table China Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table Japan Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table Japan Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table India Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table India Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Intravenous Immunoglobulins market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table MEA Intravenous Immunoglobulins market, by country, 2015 - 2026 (USD Million)
-
Table MEA Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table MEA Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table MEA Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Intravenous Immunoglobulins market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Intravenous Immunoglobulins market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Intravenous Immunoglobulins market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Hualan Biological Engineering Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biotest Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table LFB Group Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Octapharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bayer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Grifols Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Shire Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bharat Serum and Vaccines Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table ADMA Biologics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table China Biologic Products Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Kedrion Biopharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanquin Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table CSL Behring Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
